Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants
- PMID: 10400718
- PMCID: PMC112705
- DOI: 10.1128/JVI.73.8.6271-6281.1999
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants
Abstract
We have examined the nature of V3 sequence variability among subtype C human immunodeficiency virus type 1 (HIV-1) sequences from plasma-derived viral RNA present in infected men from Malawi. Sequence variability was assessed by direct sequence analysis of the V3 reverse transcription-PCR products, examination of virus populations by a subtype C V3-specific heteroduplex tracking assay (V3-HTA), and selected sequence analysis of molecular clones derived from the PCR products. Sequence variability in V3 among the subtype C viruses was not associated with the presence of basic amino acid substitutions. This observation is in contrast to that for subtype B HIV-1, where sequence variability is associated with such substitutions, and these substitutions are determinants of altered coreceptor usage. Evolutionary variants in subtype C V3 sequences, as defined by the V3-HTA, were not correlated with the CD4 level in the infected person, while such a correlation was found with subtype B V3 sequences. Viruses were isolated from a subset of the subjects; all isolates used CCR5 and not CXCR4 as a coreceptor, and none was able to grow in MT-2 cells, a hallmark of the syncytium-inducing phenotype that is correlated with CXCR4 usage. The overall sequence variability of the subtype C V3 region was no greater than that of the conserved regions of gp120. This limited sequence variability was also a feature of subtype B V3 sequences that do not carry the basic amino acid substitutions associated with altered coreceptor usage. Our results indicate that altered coreceptor usage is rare in subtype C HIV-1 isolates in sub-Saharan Africa and that sequence variability is not a feature of the V3 region of env in the absence of altered coreceptor usage.
Figures





Similar articles
-
Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.J Virol. 1999 Jul;73(7):5520-6. doi: 10.1128/JVI.73.7.5520-5526.1999. J Virol. 1999. PMID: 10364300 Free PMC article.
-
[Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].Zhonghua Yi Xue Za Zhi. 2004 Dec 2;84(23):1968-72. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15730807 Chinese.
-
Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.Virology. 2006 Dec 5-20;356(1-2):95-105. doi: 10.1016/j.virol.2006.07.030. Epub 2006 Aug 30. Virology. 2006. PMID: 16942785
-
Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.J Virol. 2003 Dec;77(24):13376-88. doi: 10.1128/jvi.77.24.13376-13388.2003. J Virol. 2003. PMID: 14645592 Free PMC article.
-
HIV-1 subtype C predicted co-receptor tropism in Africa: an individual sequence level meta-analysis.AIDS Res Ther. 2020 Feb 7;17(1):5. doi: 10.1186/s12981-020-0263-x. AIDS Res Ther. 2020. PMID: 32033571 Free PMC article. Review.
Cited by
-
Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.J Virol. 2001 Jan;75(2):579-88. doi: 10.1128/JVI.75.2.579-588.2001. J Virol. 2001. PMID: 11134270 Free PMC article.
-
Clinical significance of HIV-1 coreceptor usage.J Transl Med. 2011 Jan 27;9 Suppl 1(Suppl 1):S5. doi: 10.1186/1479-5876-9-S1-S5. J Transl Med. 2011. PMID: 21284904 Free PMC article. Review.
-
A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics.Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):176-81. doi: 10.1073/pnas.98.1.176. Proc Natl Acad Sci U S A. 2001. PMID: 11120887 Free PMC article.
-
Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching.J Virol. 2004 Jul;78(14):7565-74. doi: 10.1128/JVI.78.14.7565-7574.2004. J Virol. 2004. PMID: 15220431 Free PMC article.
-
Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina).J Virol. 2000 Jul;74(14):6501-10. doi: 10.1128/jvi.74.14.6501-6510.2000. J Virol. 2000. PMID: 10864663 Free PMC article.
References
-
- Alizon M, Wain-Hobson S, Montagnier L, Sonigo P. Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell. 1986;46:63–74. - PubMed
-
- Alkhatib G, Combadiere C, Broder C C, Feng Y, Kennedy P E, Murphy P M, Berger E A. CC CKR5: a RANTES, MIP-1a, MIP-1b receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996;272:1955–1958. - PubMed
-
- Anzala A O, Ball T B, Rostron T, O’Brien S J, Plummer F A, Rowland-Jones S L University of Nairobi Collaboration for HIV Research. CCR2-64I allele and genotype association with delayed AIDS progression in African women. Lancet. 1998;351:1632–1633. - PubMed
-
- Anzala O A, Nagelkerke N J, Bwayo J J, Holton D, Moses S, Ngugi E N, Ndinya-Achola J O, Plummer F A. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis. 1995;171:686–689. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials